Chandrapur Arneja Heart Institute Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 18-12-2024
- Paid Up Capital ₹ 2.00 M
as on 18-12-2024
- Company Age 15 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Revenue %
(FY 2022)
- Ebitda
- Net Worth
- Total Assets 0.47%
(FY 2022)
About Chandrapur Arneja Heart Institute
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 2.00 M, as per Ministry of Corporate Affairs (MCA) records.
Jaspal Arneja and Inderpreet Jaspalsingh serve as directors at the Company.
- CIN/LLPIN
U85110MH2009PTC196446
- Company No.
196446
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Oct 2009
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Nagpur, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Chandrapur Arneja Heart Institute?
Board Members(2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Jaspal Arneja | Director | 15-Oct-2009 | Current |
Inderpreet Jaspalsingh | Director | 15-Oct-2009 | Current |
Financial Performance and Corporate Structure Insights of Chandrapur Arneja Heart Institute.
Chandrapur Arneja Heart Institute Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets |
| ||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
What is the Ownership and Shareholding Structure of Chandrapur Arneja Heart Institute?
In 2019, Chandrapur Arneja Heart Institute had a promoter holding of 100.00%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Arneja Institute Of Cardiology Private LimitedActive 27 years 6 months
Jaspal Arneja and Inderpreet Jaspalsingh are mutual person
- Arneja Nagrik Hospital Private LimitedActive 11 years 10 months
Jaspal Arneja and Inderpreet Jaspalsingh are mutual person
- Baba Tradelink Private LimitedActive 17 years 6 months
Jaspal Arneja and Inderpreet Jaspalsingh are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Chandrapur Arneja Heart Institute?
Unlock and access historical data on people associated with Chandrapur Arneja Heart Institute, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Chandrapur Arneja Heart Institute, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chandrapur Arneja Heart Institute's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.